Virios Therapeutics LLC - ESG Rating & Company Profile powered by AI
Other corporations in the scoring industry group for Virios Therapeutics LLC are shown. This Disclosure rating includes 17 United Nations SDGs including: 'No Poverty', 'Decent Work & Economic Growth' and 'Life on Land'. Browse to the bottom of the page for potential risks for Virios Therapeutics LLC based on industry, geography and size.
Virios Therapeutics LLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 8.0, social score of 2.7 and governance score of 8.0.
6.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 427 | Scancell Holdings PLC | 6.3 | High |
| 427 | Verastem Inc | 6.3 | High |
| 450 | Virios Therapeutics LLC | 6.2 | High |
| 450 | Cannasouth Ltd | 6.2 | High |
| 450 | CareDx International AB | 6.2 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Virios Therapeutics LLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Virios Therapeutics LLC report the average age of the workforce?
Sign up for free to unlockDoes Virios Therapeutics LLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose cybersecurity risks?
Sign up for free to unlockDoes Virios Therapeutics LLC offer flexible work?
Sign up for free to unlockDoes Virios Therapeutics LLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Virios Therapeutics LLC conduct supply chain audits?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Virios Therapeutics LLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose water use targets?
Sign up for free to unlockDoes Virios Therapeutics LLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Virios Therapeutics LLC have a product recall in the last two years?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose incidents of discrimination?
Sign up for free to unlockDoes Virios Therapeutics LLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Virios Therapeutics LLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose parental leave metrics?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Virios Therapeutics LLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Virios Therapeutics LLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Virios Therapeutics LLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose its waste policy?
Sign up for free to unlockDoes Virios Therapeutics LLC report according to TCFD requirements?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose energy use targets?
Sign up for free to unlockDoes Virios Therapeutics LLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Virios Therapeutics LLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Virios Therapeutics LLC
These potential risks are based on the size, segment and geographies of the company.
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.